We examined the kinetics and the nature of the association of two herpes simplex virus proteins, the major DNA-binding protein (ICP8) and the major capsid protein (ICP5), with the nuclei of infected cells. We defined a series of stages in the association of the ICP8 protein with the cell nucleus. (i) Immediately after synthesis, the protein was found in the cytoplasmic fraction but associated rapidly with the crude nuclear fraction. (ii) The initial association of ICP8 with the crude nuclear fraction was detergent sensitive but DNase resistant, and, thus, the protein was either bound to structures attached to the outside of the nucleus and had not penetrated the nuclear DNA. Thus, nuclear association of the DNA-binding protein did not require viral DNA replication. More important is the observation that there is a series of stages in the nuclear association of this protein, and, thus, there may be a succession of binding sites for this protein in the cell during its movement to its final site of action in the nucleus. The major capsid protein showed some similar stages of association with the cell nucleus but the initial association with the nucleus followed a lag period. Its early association with the crude nuclear fraction was also detergent sensitive but was resistant to detergent treatment at later times. Its association with the cell nucleus was almost completely resistant to DNase treatment at all times. Inhibition of viral DNA replication blocked the nuclear transport of this protein. Thus, these two viral proteins share some stages in nuclear transport, although their requirements for nuclear association are different.
DNase treatment. Our results argue that at this stage ICP8 was bound to viral DNA. Thus, nuclear association of the DNA-binding protein did not require viral DNA replication. More important is the observation that there is a series of stages in the nuclear association of this protein, and, thus, there may be a succession of binding sites for this protein in the cell during its movement to its final site of action in the nucleus. The major capsid protein showed some similar stages of association with the cell nucleus but the initial association with the nucleus followed a lag period. Its early association with the crude nuclear fraction was also detergent sensitive but was resistant to detergent treatment at later times. Its association with the cell nucleus was almost completely resistant to DNase treatment at all times. Inhibition of viral DNA replication blocked the nuclear transport of this protein. Thus, these two viral proteins share some stages in nuclear transport, although their requirements for nuclear association are different.
A large number of eucaryotic cellular and viral proteins are located in the cell nucleus and are involved in transcription, regulation of transcription, DNA replication, and maintenance of nuclear structure. However, very little is known about the mechanism by which these proteins are localized to the cell nucleus. As a model system for the association of proteins with the cell nucleus, we studied two proteins encoded by herpes simplex virus (HSV). Like many DNA viruses, the HSV genome is rapidly transported into the cell nucleus after infection of a host cell. There, the viral DNA is transcribed by host cell polymerases. The resulting mRNA is translated in the cytoplasm to yield the alpha or immediate early viral proteins. These proteins are transported into the nucleus and modify viral RNA transcription or processing so that new mRNAs are produced. These new mRNAs are translated to yield the beta or early proteins. Many of the beta proteins are transported into the nucleus and promote the replication of the viral DNA. After viral DNA replication, the rate of synthesis of certain polypeptides is increased; others appear to be synthesized only after DNA replication. These polypeptides are collectively called the gamma or late polypeptides (24) .
The major large DNA-binding protein encoded by HSV is a beta or early protein of 128,000 to 130,000 molecular weight (1, 19, 21, 26) . It binds to single-stranded or double-stranded DNA and is known as ICP8 (infected cell polypeptide 8) or VP130 (viral protein 130). Fenwick et al. (6) have shown that this protein associates with the cell nucleus in infected cells and in vitro. Also, a temperature-sensitive mutant with a lesion mapping in or near the ICP8 coding sequences is defective for viral DNA NUCLEAR TRANSPORT OF HSV PROTEINS 315 replication and late gene expression (5) . Thus, this gene product may be involved directly in one or both of these processes. This protein is not incorporated into virions (10) .
The major capsid protein of the HSV virion is a protein of approximately 150,000 molecular weight. It is classified as a gamma protein because it is synthesized at peak rates at late times (10) . Furthermore, the expression of this protein is lowered by inhibition of viral DNA replication (5) . However, conditions that totally inhibit viral DNA replication do not completely inhibit the synthesis of this polypeptide. Thus, this gene has been defined as one that does not require viral DNA replication for its expression but whose expression is stimulated by viral DNA replication (5) . This protein also accumulates in the nucleus, where capsid assembly occurs, and is incorporated into virions as part of the capsid.
In this paper, we describe the steps in the association of these two viral proteins with the host cell nucleus. Although the requirements for their nuclear accumulation are different, the two proteins share certain intermediate stages in this process. Our results define a series of different stages of association of these proteins with the cell nucleus before binding to their final site in the cell nucleus.
MATERIALS AND METHODS
Cells and viruses. Vero cell monolayer cultures were used for the preparation of all virus stocks and experimental infections. Virus preparations were titrated on Vero cells, using an overlay of medium 199 containing 1% heat-inactivated calf serum and 0.1% human immune serum. The origin of HSV type 1 strain mP was described by Hoggan and Roizman (9) . HSV type 1 strain KOS and a temperature-sensitive mutant, tsD9 (13) were added and gently mixed. The solution was incubated at 20°C for 20 min. The nuclei were recovered by centrifugation at 2,000 rpm for 5 min. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Nuclear pellets or acetone precipitates were dissolved in gel sample buffer containing 60 mM Trishydrochloride, pH 7.6, 2% sodium dodecyl sulfate (Bio-Rad Laboratories), 20% glycerol, and 0.5% mercaptoethanol, boiled for 2 min, and subjected to electrophoresis in diallyltartardiamide cross-linked 9.25% acrylamide gels similar to those used by Heine et al. (8) . The gels were fixed, stained with Coomassie brilliant blue, dried, and exposed to Kodak SB-5 single-side emulsion X-ray film. The resulting autoradiograms were scanned with a Joyce-Loebl microdensitometer, and peak areas were determined with a Keufel and Esser planimeter. (Fig. lb) . The pellet after the detergent treatment consisted largely of nuclei that had lost the contaminating cytoplasm and appeared to be bounded by a diffuse, fibrous matrix rather than a lipid bilayer ( Fig. lc and d) . We the rRNA was recovered with the cytoplasmic and detergent wash fractions (L. Rafield and D. Knipe, unpublished data). In addition, we found that all of the cellular histones were recovered in the detergent-washed nuclear fraction (data not shown). Thus, the nuclei appear to be purified intact by this protocol with minimal cytoplasmic contamination. Also, this fractionation appears to be similar to that for uninfected HeLa cells (18) . On this basis, we have termed the initial pellet after homogenization as the crude nuclear fraction and the supernatant as the cytoplasmic fraction. The pellet after detergent treatment is described as the nuclear fraction, and the supernatant is described as the detergent wash fraction. Figure 2 shows the viral proteins present in the three fractions: nucleus, cytoplasm, and detergent wash. The major large proteins in the nuclei were ICP5, the major capsid protein, and ICP8, the DNA-binding protein, with lesser amounts of ICP36 and ICP39. bound to the matrix. We currently know nothing more concerning the identity of these two polypeptides. Kinetics of nuclear association. To examine the kinetics of association of ICP5 and ICP8 with the various cell fractions, we fractionated infected cells at various times during a chase period after a 5-min pulse-label. The amount of labeled ICP5 and ICP8 was roughly constant after 10 min of chase. An increase in the amount of labeled ICP5 and ICP8 was observed between the end of the labeling period and 10 min into the chase period. Presumably, this was due to completion of nascent chains because the total amount of incorporated radioactivity did not increase during this time (data not shown). ICP8 was initially found in the cytoplasm and quickly associated with the crude nuclear fraction (Fig. 3a) . By 10 The culture was incubated with excess methionine for 2 h at 37°C and fractionated as described in the text into the nuclear (N), cytoplasmic (C), and detergent wash (W) fractions. The proteins from these fractions were subjected to gel electrophoresis. Shown is the autoradiogram of the dried gel.
RESULTS

Fractionation
gether. Small amounts of other proteins were also present in the nuclear fraction. Many virusspecific proteins were found in the cytoplasm, e.g., ICP11, ICP20, and ICP26. Most min of chase, approximately one-half of this protein was bound to a crude nuclear structure. However, at early times of the chase period, a high percentage of the ICP8 that was associated with the nucleus after Dounce homogenization could be removed by detergents (Fig. 3b) . At later times (40 to 120 min), a high percentage of the ICP8 associated with the nucleus was resistant to detergents. Thus, the nucleus-associated ICP8 which can be removed by detergents appeared to represent an intermediate stage in the association of ICP8 with the cell nucleus. The maximum level of this form occurred at 10 to 20 min into the chase period.
The kinetics of association of ICP5 with the cell nucleus followed the same general pattern, except that the initial association with the crude nuclear fraction occurred at a slower rate than that of ICP8 (Fig. 4) . Approximately 30 min was required for one-half of ICP5 to associate with the crude nuclear fraction (Fig. 4a) . As with ICP8, the early association of ICP5 with the crude nuclear fraction was largely detergent sensitive, whereas later the association with the nuclear fraction was resistant to detergent treatment (Fig. 4b) Treatment of nuclei with detergents and DNase. The experiments described above defined detergent-resistant or DNase-resistant associations of ICP8 with the cell nucleus. To determine whether any nuclear form of ICP8 was resistant to both detergent and DNase treatments, we isolated nuclei at various times during a chase period after a 5-min pulse-label and treated them with both DNase and a detergent mixture (Fig. 7) . The amount of ICP8 that was resistant to both treatments increased at a low rate until at least 40 min of chase but declined by 120 min of chase. Thus, this form of ICP8 was present at maximal levels at intermediate times we examined the transport of these proteins in infected cells maintained in the presence of phosphonoacetate (PAA), a potent inhibitor of HSV DNA replication (7, 11, 16) . This drug inhibits the action of the HSV DNA polymerase, apparently by binding to the polymerase at the pyrophosphate site (14) . Infected (Fig. 8 and 9 ). Addition of PAA lowered the rate of synthesis of ICP5 as previously reported (5) and reduced the nuclear transport of the residual ICP5. In contrast, inhibition of viral DNA replication by PAA did not lead to an altered rate of synthesis of ICP8 ( Fig.  8 and 9 ) (M. Quinlan and D. Knipe, unpublished data). Inhibition of viral DNA synthesis by PAA did not inhibit the nuclear transport of ICP8; rather, it enhanced the rate or extent of transport such that the fraction of ICP8 in the detergent-washed nuclear fraction of PAA-treated cells exceeded that in control cells (Fig. 8 and 9 ). Thus, the nuclear uptake of the DNA-binding protein was not dependent on viral DNA replica- nuclei with DNase I (Fig. 8) . DNase treatment removed approximately 70% of ICP8 from control nuclei but less than 1% from the nuclei of cells maintained in PAA. Thus, in the absence of viral DNA replication, ICP8 accumulated in the nucleus in a form resistant to both detergent and DNase treatment, possibly the same form as the intermediate described above. These experiments also argued that: (i) ICP8 eventually associated with viral DNA in control cells; and (ii) ICP8 can associate stably with other nuclear structures in the absence of viral DNA replication. These other structures could be the nuclear matrix as will be discussed below.
Reversal of a block in DNA replication. To determine whether the association of ICP8 with the cell nucleus in the presence of PAA represented the accumulation of an intermediate form or an irreversible end product, we wished to reverse the block in DNA replication by removal of the PAA. However, others have shown that reversal from a PAA block is slow and incomplete (R. Jacob and B. Roizman, unpublished data). Therefore, to reverse a block in DNA replication, we have instead performed an experiment which employed the temperature shift of cells infected with the HSV type 1 temperature-sensitive mutant KOS tsD9 (13, 20) , which encodes a thermolabile DNA polymerase (20 and subjected the cells to chase conditions for 2 h at 39°C. Cultures were harvested at the times shown in Table 1 , and the crude nuclei were isolated and subjected to DNase I treatment. After 2 h of chase, nuclei from the cells infected with wild-type virus showed approximately 40% removal of ICP8 by DNase, whereas the mutantinfected nuclei showed no removal (Table 1) . Thus, use of a mutant defective in DNA replication also led to accumulation of ICP8 in the nucleus in a DNase-resistant form. After 4 h of chase at 39°C, cells infected with tsD9 showed about 30% removal of the ICP8 by DNase treatment, perhaps due to leak-through synthesis of viral DNA. However, a shift to the permissive temperature of cells infected with tsD9 allowed about 60% of the ICP8 to be released from the nuclei by DNase. The decreased amount of ICP8 in tsD9-infected cells kept at 39°C (Table 1) was not observed in other experiments, but the same change in ICP8 location was observed in cells shifted to 34°C. Thus, reversal of the block in DNA replication allowed the ICP8 to be converted from a DNase-resistant form to a form that could be released by DNase. We interpret this to mean that ICP8 which is stably bound to the nucleus in a structure not involving viral DNA can later associate with viral DNA as it is synthesized.
DISCUSSION
The HSV genome is transcribed and replicated in the infected-cell nucleus, but the virusencoded proteins are synthesized in the cytoplasm. Therefore, specific viral proteins must be transported into the cell nucleus. We are studying this process in an attempt to understand how specific proteins accumulate in the cell nucleus. Two viral proteins, the major DNA-binding Nuclear association of the DNA-binding protein. We found that ICP8, the major DNAbinding protein, was initially localized in the cytoplasmic fraction but quickly associated with the crude nuclear fraction. Three stages of association of ICP8 with the crude nuclear fraction were operationally defined by treatment of this subcellular fraction with DNase, detergents, or both. First, at early times during a chase period, a high proportion of the ICP8 that was associated with the nucleus was released by detergent treatment but was resistant to DNase treatment. This state could represent a form of ICP8 that was bound to the cytoskeleton attached to the outside of the nucleus, bound to the nuclear membrane, in transit through the nuclear pores, or loosely bound to the nucleus. ICP8 appeared not to be bound to a structure involving viral DNA at this time.
The second stage was defined as a form of ICP8 that was observed at intermediate times of the chase and whose attachment to nuclei was resistant to both detergents and DNase. This form was observed at low levels during normal infections but appeared to be equivalent to a detergent-resistant, DNase-resistant form that accumulated in the absence of viral DNA replication. The identity of the structure to which ICP8 was bound in this form is not known. Preliminary results have shown that in PAAtreated nuclei ICP8 copurified extensively with the nuclear matrix proteins (M. Quinlan and D. Knipe, manuscript in preparation). This suggests that ICP8 is bound to the nuclear framework called the nuclear matrix (2 Our studies thus far have yielded a limited amount of information about the pathway by which the HSV proteins penetrate the nuclear envelope. Because both proteins studied in detail were found as cytoplasmic forms soon after their synthesis, it seems unlikely that they are synthesized on polyribosomes bound to the outer nuclear membrane and directly extruded into the lumen and rapidly transported across the inner membrane. We cannot exclude the possibility that they are synthesized on the endoplasmic reticulum and travel through the lumen to the inner nuclear membrane. The more likely route of entry is through the cytoplasm and nuclear pores. If so, it seems likely that proteins of 120,000 to 150,000 molecular weight must be folded to pass through the pores (2) . Preliminary studies have shown that the cytoplasmic form of ICP8 is a rapidly sedimenting structure (M. Quinlan and D. Knipe, unpublished data). Further studies are in progress to characterize the structure and metabolism of this form of ICP8 to further understand how this protein is transported into the cell nucleus.
